Innovation is in GenSci's DNA. GenSci advances a robust, innovative portfolio across four therapeutic areas: endocrinology & metabolism, immunology & respiratory diseases, ophthalmology, oncology, and women's health.
Guided by global R&D strategy, besides robust research engines, we execute Multi-Regional Clinical Trials (MRCT) with high efficiency and high standards in China and overseas. Our innovation engine is powered by cutting-edge technology platforms, enhanced by AI to enable precision-targeting therapeutic development.
Concurrently, we are building a global R&D network to foster worldwide collaboration. This network is crucial for accelerating our research and development of innovative medicines and ensures our research outcomes finely calibrated to address the complex and diverse needs of global markets.
-
40+
Pipeline
-
6
Multi-Regional Clinical Trials
-
26.5%
R&D investment
(% of 2025 revenue) -
90+
Patents
Highlights
Harnessing advanced platforms to advance first-in-class pipelines addressing major diseases.
-
AI-EmpoweredLeverage AI to speed drug discovery and development
AI-EmpoweredLeverage AI to speed drug discovery and development
-
Top TechnologyDevelop differentiated and leading platforms
Top TechnologyDevelop differentiated and leading platforms
-
Unmet NeedsFocus on therapeutic areas with clinical unmet needs
Unmet NeedsFocus on therapeutic areas with clinical unmet needs
-
Large InvestmentInvest significantly in R&D
Large InvestmentInvest significantly in R&D
-
Global CooperationTeam up with innovators worldwide
Global CooperationTeam up with innovators worldwide
R&D Centers
Five major R&D centers power unceasing innovation
-
Shanghai R&D CenterShanghai R&D Center
Equipped to house 2,000 R&D professionals, this state-of-the-art facility leads in translational medicine and clinical research. It is at the forefront of discovering new drug targets and forging strategic alliances to convert innovative ideas into practical medical solutions.
-
Changchun R&D CenterChangchun R&D Center
Serves as a vibrant hub of innovation and a nucleus for the industrialization of biopharmaceuticals and chemical medicines, deftly guiding the product development lifecycle from inception to successful market entry.
-
Beijing R&D CenterBeijing R&D Center
Actively conducts essential medical research and rigorously oversees the new product registration process to meet exacting regulatory standards, critical for our strategic market expansion and product diversification within China.
-
U.S. R&D CenterU.S. R&D Center
Located in Boston, the center serves as a strategic hub for advancing our R&D capabilities and accelerating our presence in the U.S. market. This center enables our R&D programs to align with global standards and emerging healthcare needs, thereby enhancing our competitiveness in the global biopharmaceutical landscape.
-
European R&D CenterEuropean R&D Center
Located in Lausanne, Switzerland, this center is pivotal to our strategic expansion across Europe, crafting R&D strategies that are in perfect harmony with European regulatory standards. It plays an essential role in keeping our products at the cutting edge of competitiveness and compliance within the European pharmaceutical market.
-
Shanghai R&D Center
Equipped to house 2,000 R&D professionals, this state-of-the-art facility leads in translational medicine and clinical research. It is at the forefront of discovering new drug targets and forging strategic alliances to convert innovative ideas into practical medical solutions.
-
Changchun R&D Center
Serves as a vibrant hub of innovation and a nucleus for the industrialization of biopharmaceuticals and chemical medicines, deftly guiding the product development lifecycle from inception to successful market entry.
-
Beijing R&D Center
Actively conducts essential medical research and rigorously oversees the new product registration process to meet exacting regulatory standards, critical for our strategic market expansion and product diversification within China.
-
U.S. R&D Center
Located in Boston, the center serves as a strategic hub for advancing our R&D capabilities and accelerating our presence in the U.S. market. This center enables our R&D programs to align with global standards and emerging healthcare needs, thereby enhancing our competitiveness in the global biopharmaceutical landscape.
-
European R&D Center
Located in Lausanne, Switzerland, this center is pivotal to our strategic expansion across Europe, crafting R&D strategies that are in perfect harmony with European regulatory standards. It plays an essential role in keeping our products at the cutting edge of competitiveness and compliance within the European pharmaceutical market.